Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,432.97
(
1.08%
)
US TECH 100
28,412.80
(
-0.40%
)
Dow Jones
50,009.35
(
0.00%
)
Brent Oil
103.73
(
1.42%
)
Bitcoin
77,114.59
(
-0.48%
)
News Focus
News Focus

Replies to post #241 on Nektar Therapeutics (NKTR)

Replies to #241 on Nektar Therapeutics (NKTR)
icon url

DewDiligence

08/08/19 5:20 PM

#242 RE: DewDiligence #241

NKTR says two production lots of NKTR-214 were substandard—possibly causing the attenuated recent responses in PIVOT-02 compared to the early responses. Ouch.